Albuterol Sulfate Aerosol, Metered
Product Images NDC 51662-1513

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 51662-1513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Box Label (45802 088 01 Albuterol Box Label (1))

Box Label (45802 088 01 Albuterol Box Label (1))
This is a product description of an Albuterol Sulfate Inhalation Aerosol with 90 mcg per actuation. The contents of this inhaler include microcrystalline suspension of albuterol sulfate in a propellant (A 134) of about 8.5g net contents. Each actuation delivers 108g albuterol sulfate equivalent to 0.0 e abutrlrom e mouthpiece. However, this product must be used only as directed by a physician. The package insert contains all the prescribing information. The product must be dispensed with care as per the pharmacist's directions. In addition, the actuator must be cleaned weekly, and discarded when the dose counter displays 0 or after the operation rate. 200 metered inhalations make up the contents of each canister. The product contains warnings for severe side effects of the drug as well.*
FDA Label Image

Serialized (45802 088 01 Albuterol Hf Label)

Serialized (45802 088 01 Albuterol Hf Label)
FDA Label Image

Clinical Studies (Clinical Studies)

Clinical Studies (Clinical Studies)
This text describes the results of a 6-week clinical trial where FEV (forced expiratory volume) was measured as mean percent change from test-day pre-dose. The percentage change in FEV on day 1 and day 43 was measured for albuterol sulfate inhalation aerosol, matched placebo HFA inhalation aerosol and marketed HFA-134a albuterol inhaler. A graph is also shown with time (in hours) on the x-axis and FEV percent change on the y-axis.*
FDA Label Image

Description (Description Photo)

Description (Description Photo)
FDA Label Image

Figure A (Ifu A B)

Figure A (Ifu A B)
This is a product that consists of a metal canister with a mouthpiece and a plastic actuator dose counter as shown in Figure A and Figure B. However, no information is provided regarding the purpose, use or brand of this product.*
FDA Label Image

Figure C (Ifu C)

Figure C (Ifu C)
FDA Label Image

Figure D (Ifu D)

Figure D (Ifu D)
The text describes the Albuterol Sulfate Inhalation Aerosol, a medication that comes with a spray counter that shows the number of sprays left for use. The medication contains 200 sprays for actual use and an additional 3 sprays for priming purposes. The spray counter reads 200 after priming the device and 203 before priming. Figure D is likely a diagram showing the Albuterol Sulfate Inhalation Aerosol and its spray counter.*
FDA Label Image

Figure E (Ifu E)

Figure E (Ifu E)
FDA Label Image

Figure F (Ifu F)

Figure F (Ifu F)
FDA Label Image

Figure Gh (Ifu G H)

Figure Gh (Ifu G H)
FDA Label Image

Figure I (Ifu I)

Figure I (Ifu I)
FDA Label Image

Figure J (Ifu J)

Figure J (Ifu J)
FDA Label Image

Figure K (Ifu K)

Figure K (Ifu K)
FDA Label Image

Adverse Reactions (Adverse Reactions 1)

Adverse Reactions (Adverse Reactions 1)
This appears to be a table with adverse events related to a study of albuterol sulfate inhalation aerosol compared to a marketed comparator and a matched placebo. Adverse events are listed by body system including headache, tachycardia, pain, dizziness, pharyngitis, and rhinitis. The number of occurrences for each adverse event is listed in a column.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.